Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
JP Stock MarketDetailed Quotes
7677 Yashima
- 2110
- +50+2.43%
20min DelayMarket Closed Dec 16 15:30 JST
6.08BMarket Cap15.38P/E (Static)
2110High2110Low200Volume2110Open2060Pre Close422.00KTurnover217252wk High0.06%Turnover Ratio2.88MShares197752wk Low135.46EPS TTM684.34MFloat Cap3360Historical High15.38P/E (Static)324.33KShs Float1202Historical Low137.16EPS LYR0.00%Amplitude25.00Dividend TTM0.62P/B100Lot Size1.18%Div YieldTTM
Yashima Key Stats
Quarterly+Annual
YOY
| (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.64%27.73B | 4.54%7.19B | 6.22%7.61B | 15.67%6.54B | 9.65%6.4B | -9.79%25.52B | -13.32%6.87B | 0.47%7.16B | -8.26%5.65B | -17.50%5.84B |
| Cost of revenue | 7.94%23.76B | 2.85%6.06B | 4.12%6.49B | 16.55%5.67B | 10.33%5.53B | -10.32%22.01B | -12.25%5.9B | 1.62%6.24B | -10.36%4.86B | -19.91%5.02B |
| Gross profit | 13.04%3.97B | 14.73%1.12B | 20.36%1.11B | 10.24%865.86M | 5.48%869.51M | -6.33%3.51B | -19.24%978.42M | -6.63%924.65M | 7.31%785.46M | 0.95%824.32M |
| Operating expense | 4.60%3.61B | 9.64%916.89M | 2.72%875.92M | 3.18%879.48M | 3.03%933.71M | 2.05%3.45B | -8.23%836.25M | 2.08%852.76M | 8.47%852.35M | 7.13%906.22M |
| Operating profit | 458.97%364.86M | 44.66%205.66M | 229.70%237.01M | 79.65%-13.61M | 21.60%-64.2M | -82.45%65.27M | -52.65%142.17M | -53.60%71.89M | -24.17%-66.89M | -179.10%-81.9M |
| Net non-operating interest income (expenses) | -46.75%5.23M | 10.73%1.51M | -29.07%1.48M | -68.29%1.15M | -60.23%1.1M | -19.02%9.82M | -42.89%1.36M | -46.26%2.08M | 24.77%3.62M | -7.08%2.76M |
| Non-operating interest income | -46.70%5.24M | 10.65%1.51M | -28.97%1.49M | -68.29%1.15M | -60.12%1.1M | -19.08%9.84M | -42.85%1.36M | -46.15%2.09M | 24.47%3.62M | -7.27%2.77M |
| Non-operating interest expense | -25.00%18K | --0 | -9.09%10K | --0 | -33.33%8K | -38.46%24K | --1K | -15.38%11K | --0 | -36.84%12K |
| Net investment income | -26.03%20.68M | -182.06%-7.12M | 32.79%8.85M | 662.14%3.2M | 29.04%15.74M | 66.44%27.95M | 656.48%8.67M | 43.66%6.66M | -79.93%420K | 4.97%12.2M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -9.38M | -6,085.63%-9.58M | 0 | 101.62%8K | -89.66%187K | 0 | 10.34%160K | -544.10%-1.48M | -143.74%-493K | 10,535.29%1.81M |
| Special income (charges) | 126.16%114.14M | 208.56%264.14M | 98.71%-1.28M | -3.43%-72.82M | -219.28%-75.9M | -436.27M | -243.31M | -98.78M | -70.41M | -23.77M |
| Less:Other special charges | ---- | ---- | --0 | --0 | --2.34M | ---- | ---- | ---- | ---- | ---- |
| Less:Write off | -126.16%-114.14M | -207.60%-261.79M | -98.71%1.28M | 3.43%72.82M | 209.43%73.56M | --436.27M | --243.31M | --98.78M | --70.41M | --23.77M |
| Other non-operating income (expenses) | -16.92%109.59M | -28.80%21.99M | -0.91%34.47M | -2.19%24.89M | -30.76%28.25M | -10.39%131.91M | 80.34%30.88M | -11.08%34.79M | -43.12%25.45M | -11.74%40.8M |
| Income before tax | 400.57%605.11M | 893.35%476.6M | 1,750.44%280.53M | 47.19%-57.19M | -97.12%-94.83M | -136.66%-201.32M | -118.87%-60.07M | -92.51%15.16M | -3,499.30%-108.3M | -252.77%-48.11M |
| Income tax | 268.03%212.62M | 504.09%106.31M | 261.15%111.37M | 247.52%3.96M | -174.96%-9.01M | -76.68%57.77M | -87.20%17.6M | -56.27%30.84M | -122.34%-2.68M | -56.60%12.02M |
| Net income | 251.48%392.48M | 576.73%370.29M | 1,179.02%169.16M | 42.11%-61.15M | -42.73%-85.82M | -185.96%-259.1M | -142.95%-77.67M | -111.89%-15.68M | -603.29%-105.62M | -1,686.86%-60.13M |
| Net income continuous operations | 251.48%392.49M | 576.74%370.29M | 1,179.03%169.16M | 42.10%-61.15M | -42.73%-85.82M | -185.96%-259.1M | -142.95%-77.67M | -111.89%-15.68M | -603.24%-105.62M | -1,686.44%-60.13M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 251.48%392.48M | 576.73%370.29M | 1,179.02%169.16M | 42.11%-61.15M | -42.73%-85.82M | -185.96%-259.1M | -142.95%-77.67M | -111.89%-15.68M | -603.29%-105.62M | -1,686.86%-60.13M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 251.48%392.48M | 576.73%370.29M | 1,179.02%169.16M | 42.11%-61.15M | -42.73%-85.82M | -185.96%-259.1M | -142.95%-77.67M | -111.89%-15.68M | -603.29%-105.62M | -1,686.86%-60.13M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 251.09%137.16 | 576.09%129.4 | 1,187.50%59.16 | 42.28%-21.38 | -42.14%-30.02 | -185.67%-90.78 | -142.76%-27.18 | -111.73%-5.44 | -601.52%-37.04 | -1,687.97%-21.12 |
| Diluted earnings per share | 251.09%137.16 | 575.58%129.264 | 1,172.46%59.0513 | 42.35%-21.3875 | -42.14%-30.02 | -185.67%-90.78 | -142.79%-27.18 | -111.88%-5.5061 | -601.48%-37.0962 | -1,687.97%-21.12 |
| Dividend per share | 0.00%25 | 0.00%25 | 0 | 0 | 0 | 0.00%25 | 0.00%25 | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |